Physician profile
Eric D Meyer
NPI 1457584740
$1,505.85
in general payments reported to CMS, 2019-2025
10 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $135 · 2023: $236 · 2024: $531 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $727.35 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $235.38 | 2022-2025 | Azstarys |
| Mdd US Operations, LLC | $225.15 | 2025 | Qelbree |
| Tris Pharma INC | $112.90 | 2022-2025 | Dyanavel Xr |
| Almatica Pharma LLC | $54.46 | 2024-2025 | Loreev Xr |
| Noven Therapeutics, LLC | $47.63 | 2024 | Xelstrym |
| Neos Therapeutics, LP | $33.51 | 2024-2025 | Cotempla Xr-Odt |
| Ironshore Pharmaceuticals INC. | $33.41 | 2024 | |
| Sunovion Pharmaceuticals INC. | $18.73 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.33 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.